Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Jazz compositions and charity coalesce in The Mingus Awareness Project. Since 2007, the project has provided opportunities for musicians to perform new arrangements of works by the venerated bassist, ...

Facing the battle of his life, Glenn Love wants his voice to be heard. During his football career – including four seasons ...

Individuals living with ALS are automatically eligible for Medicare when they start receiving Social Security benefits. Medicare should cover most diagnostics and treatments, but this depends on the ...

Western student applying occupational therapy to her ALS experience to help other families manage their daily lives with physical or cognitive impairment.

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.